Abstract
Get full access to this article
View all access options for this article.
References
1.
Woosley
RL
Yiwang
C
Freiman
JP
Gillis
RA
. Mechanism of the cardiotoxic actions of terfenadine . JAMA
1993 ; 269 : 1532 –6 .
2.
Honig
PK
Wortham
DC
Zamani
K
Conner
DP
Mullin
JC
Cantilena
LR
. Terfenadine-ketoconazole interaction . JAMA
1993 ; 269 : 1513 –8 .
3.
Honig
PK
Woosley
RL
Zamani
K
Conner
DP
Cantilena
LR
. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin . Clin Pharmacol Ther
1992 ; 52 : 231 –8 .
4.Safety of terfenadine and astemizole . Med Lett Drugs Ther
1992 ; 34 : 9 –10 .
5.
Levinson
ML
Lipsy
RJ
Fuller
DK
. Adverse effects and drug interactions associated with fluoxetine therapy . DICP Ann Pharmacother
1991 ; 25 : 657 –61 .
6.
Sommi
R
Crismon
L
Bowden
C
. Fluoxetine: a serotonin-specific second generation antidepressant . Pharmacotherapy
1987 ; 7 : 1 –15 .